Definition epidemiology natural history and clinical phases

Vamsi Kota, Kavita Natrajan

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Chronic Myeloid Leukemia (CML) is a relatively rare hematological malignancy with just over 5000 cases diagnosed annually in the United States. It is a disease found in the elderly with a median age in the 60s and it is rarely seen in children. It has the characteristic Philadelphia chromosome first identified in 1960. This has lead to tremendous revolution in the field of CML with the past 10 years leading to spectacular improvement in outcomes in this disease. The natural history of the disease has changed dramatically with the addition of the tyrosine kinase inhibitors and most of the information about the course of the disease is from studies prior to the introduction of the tyrosine kinases. Most of the patients present with chronic phase with progression to the blast phase eventually with differentiation arrest.

Original languageEnglish (US)
Title of host publicationChronic Myeloid Leukemia
Subtitle of host publicationFrom Daily Management to Complicated Issues
PublisherNova Science Publishers, Inc.
Pages3-10
Number of pages8
ISBN (Electronic)9781629489926
ISBN (Print)9781629489711
StatePublished - Jan 1 2014

Fingerprint

Natural History
Epidemiology
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Protein-Tyrosine Kinases
Blast Crisis
Philadelphia Chromosome
Hematologic Neoplasms

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Kota, V., & Natrajan, K. (2014). Definition epidemiology natural history and clinical phases. In Chronic Myeloid Leukemia: From Daily Management to Complicated Issues (pp. 3-10). Nova Science Publishers, Inc..

Definition epidemiology natural history and clinical phases. / Kota, Vamsi; Natrajan, Kavita.

Chronic Myeloid Leukemia: From Daily Management to Complicated Issues. Nova Science Publishers, Inc., 2014. p. 3-10.

Research output: Chapter in Book/Report/Conference proceedingChapter

Kota, V & Natrajan, K 2014, Definition epidemiology natural history and clinical phases. in Chronic Myeloid Leukemia: From Daily Management to Complicated Issues. Nova Science Publishers, Inc., pp. 3-10.
Kota V, Natrajan K. Definition epidemiology natural history and clinical phases. In Chronic Myeloid Leukemia: From Daily Management to Complicated Issues. Nova Science Publishers, Inc. 2014. p. 3-10
Kota, Vamsi ; Natrajan, Kavita. / Definition epidemiology natural history and clinical phases. Chronic Myeloid Leukemia: From Daily Management to Complicated Issues. Nova Science Publishers, Inc., 2014. pp. 3-10
@inbook{90faacac20a349e4a239e1bac2ada823,
title = "Definition epidemiology natural history and clinical phases",
abstract = "Chronic Myeloid Leukemia (CML) is a relatively rare hematological malignancy with just over 5000 cases diagnosed annually in the United States. It is a disease found in the elderly with a median age in the 60s and it is rarely seen in children. It has the characteristic Philadelphia chromosome first identified in 1960. This has lead to tremendous revolution in the field of CML with the past 10 years leading to spectacular improvement in outcomes in this disease. The natural history of the disease has changed dramatically with the addition of the tyrosine kinase inhibitors and most of the information about the course of the disease is from studies prior to the introduction of the tyrosine kinases. Most of the patients present with chronic phase with progression to the blast phase eventually with differentiation arrest.",
author = "Vamsi Kota and Kavita Natrajan",
year = "2014",
month = "1",
day = "1",
language = "English (US)",
isbn = "9781629489711",
pages = "3--10",
booktitle = "Chronic Myeloid Leukemia",
publisher = "Nova Science Publishers, Inc.",

}

TY - CHAP

T1 - Definition epidemiology natural history and clinical phases

AU - Kota, Vamsi

AU - Natrajan, Kavita

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Chronic Myeloid Leukemia (CML) is a relatively rare hematological malignancy with just over 5000 cases diagnosed annually in the United States. It is a disease found in the elderly with a median age in the 60s and it is rarely seen in children. It has the characteristic Philadelphia chromosome first identified in 1960. This has lead to tremendous revolution in the field of CML with the past 10 years leading to spectacular improvement in outcomes in this disease. The natural history of the disease has changed dramatically with the addition of the tyrosine kinase inhibitors and most of the information about the course of the disease is from studies prior to the introduction of the tyrosine kinases. Most of the patients present with chronic phase with progression to the blast phase eventually with differentiation arrest.

AB - Chronic Myeloid Leukemia (CML) is a relatively rare hematological malignancy with just over 5000 cases diagnosed annually in the United States. It is a disease found in the elderly with a median age in the 60s and it is rarely seen in children. It has the characteristic Philadelphia chromosome first identified in 1960. This has lead to tremendous revolution in the field of CML with the past 10 years leading to spectacular improvement in outcomes in this disease. The natural history of the disease has changed dramatically with the addition of the tyrosine kinase inhibitors and most of the information about the course of the disease is from studies prior to the introduction of the tyrosine kinases. Most of the patients present with chronic phase with progression to the blast phase eventually with differentiation arrest.

UR - http://www.scopus.com/inward/record.url?scp=84950326572&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84950326572&partnerID=8YFLogxK

M3 - Chapter

SN - 9781629489711

SP - 3

EP - 10

BT - Chronic Myeloid Leukemia

PB - Nova Science Publishers, Inc.

ER -